ArticleFrontiers in medicine2023

Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1).

Marigdalia K Ramirez-Fort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.